Effects of eugenol on Na+ currents in rat dorsal root ganglion neurons

Brain Research

Volumn 1243, Issue , 2008, Pages 53-62

  Cho, Jeong Seon ^a   Kim, Tae Hoon ^a   Lim, Jae Min ^a   Song, Jin Ho ^a  

^a Chung Ang University   (South Korea)

Author keywords

Dorsal root ganglion; Eugenol; Na+ current; Tetrodotoxin resistant; Tetrodotoxin sensitive

Indexed keywords

CAPSAICIN; EUGENOL; TETRODOTOXIN; VOLTAGE GATED SODIUM CHANNEL;

ANALGESIA; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; GENE EXPRESSION; INFLAMMATION; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM CURRENT; SPINAL GANGLION; STEADY STATE;

ANALGESICS; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EUGENOL; GANGLIA, SPINAL; ION CHANNEL GATING; MEMBRANE POTENTIALS; NOCICEPTORS; PAIN; PATCH-CLAMP TECHNIQUES; RATS; SENSORY RECEPTOR CELLS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TETRODOTOXIN;

RATTUS;

EID: 55649083905     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.09.030     Document Type: Article

References (44)

1. Akopian A.N., Sivilotti L., and Wood J.N. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379 (1996) 257-262
2. Akopian A.N., Souslova V., England S., Okuse K., Ogata N., Ure J., Smith A., Kerr B.J., McMahon S.B., Boyce S., Hill R., Stanfa L.C., Dickenson A.H., and Wood J.N. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat. Neurosci. 2 (1999) 541-548
3. 2+ channels to treat pain: T-type versus N-type. Trends Pharmacol. Sci. 25 (2004) 465-470
4. v1.9 is an effector of peripheral inflammatory pain hypersensitivity. J. Neurosci. 26 (2006) 12852-12860
5. A receptors expressed in Xenopus oocytes by perfume and phytoncid. Biosci. Biotechnol. Biochem. 63 (1999) 743-748
6. Black J.A., Liu S., Tanaka M., Cummins T.R., and Waxman S.G. Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain 108 (2004) 237-247
7. Brodin P. Differential inhibition of A, B and C fibres in the rat vagus nerve by lidocaine, eugenol and formaldehyde. Arch. Oral Biol. 30 (1985) 477-480
8. Cox J.J., Reimann F., Nicholas A.K., Thornton G., Roberts E., Springell K., Karbani G., Jafri H., Mannan J., Raashid Y., Al-Gazali L., Hamamy H., Valente E.M., Gorman S., Williams R., McHale D.P., Wood J.N., Gribble F.M., and Woods C.G. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444 (2006) 894-898
9. Cummins T.R., Sheets P.L., and Waxman S.G. The roles of sodium channels in nociception: implications for mechanisms of pain. Pain 131 (2007) 243-257
10. Dib-Hajj S.D., Tyrrell L., Black J.A., and Waxman S.G. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 8963-8968
11. + channel α subunit protein. J. Physiol. 546 (2003) 565-576
12. Dohi T., Anamura S., Shirakawa M., Okamoto H., and Tsujimoto A. Inhibition of lipoxygenase by phenolic compounds. Jpn. J. Pharmacol. 55 (1991) 547-550
13. V1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats. Neuroscience 146 (2007) 812-821
14. v1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 17030-17035
15. Fertleman C.R., Baker M.D., Parker K.A., Moffatt S., Elmslie F.V., Abrahamsen B., Ostman J., Klugbauer N., Wood J.N., Gardiner R.M., and Rees M. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52 (2006) 767-774
16. v1.7 gene underlie congenital indifference to pain in multiple human populations. Clin. Genet. 71 (2007) 311-319
17. Goldin A.L. Resurgence of sodium channel research. Annu. Rev. Physiol. 63 (2001) 871-894
18. Guenette S.A., Beaudry F., Marier J.F., and Vachon P. Pharmacokinetics and anesthetic activity of eugenol in male Sprague-Dawley rats. J. Vet. Pharmacol. Ther. 29 (2006) 265-270
19. Guenette S.A., Ross A., Marier J.F., Beaudry F., and Vachon P. Pharmacokinetics of eugenol and its effects on thermal hypersensitivity in rats. Eur. J. Pharmacol. 562 (2007) 60-67
20. v1.7. Ann. Neurol. 59 (2006) 553-558
21. Irie Y., and Keung W.M. Rhizoma acori graminei and its active principles protect PC-12 cells from the toxic effect of amyloid-β peptide. Brain Res. 963 (2003) 282-289
22. Ito S., Okuda-Ashitaka E., and Minami T. Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci. Res. 41 (2001) 299-332
23. v1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 8520-8525
24. Kim S.S., Oh O.J., Min H.Y., Park E.J., Kim Y., Park H.J., Han Y.N., and Lee S.K. Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Life Sci. 73 (2003) 337-348
25. Koseoglu B.G., Tanrikulu S., Subay R.K., and Sencer S. Anesthesia following overfilling of a root canal sealer into the mandibular canal: a case report. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endo. 101 (2006) 803-806
26. Kozam G. The effect of eugenol on nerve transmission. Oral Surg. Oral Med. Oral Pathol. 44 (1977) 799-805
27. Kozam G., and Mantell G.M. The effect of eugenol on oral mucous membranes. J. Dent. Res. 57 (1978) 954-957
28. V1.8. Pain 95 (2002) 143-152
29. Lee M.H., Yeon K.Y., Park C.K., Li H.Y., Fang Z., Kim M.S., Choi S.Y., Lee S.J., Lee S., Park K., Lee J.H., Kim J.S., and Oh S.B. Eugenol inhibits calcium currents in dental afferent neurons. J. Dent. Res. 84 (2005) 848-851
30. Li W., Tsubouchi R., Qiao S., Haneda M., Murakami K., and Yoshino M. Inhibitory action of eugenol compounds on the production of nitric oxide in RAW264.7 macrophages. Biomed. Res. 27 (2006) 69-74
31. Müller M., Pape H.C., Speckmann E.J., and Gorji A. Effect of eugenol on spreading depression and epileptiform discharges in rat neocortical and hippocampal tissues. Neuroscience 140 (2006) 743-751
32. Nangle M.R., Gibson T.M., Cotter M.A., and Cameron N.E. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats. Planta Med. 72 (2006) 494-500
33. Ohkubo T., and Shibata M. The selective capsaicin antagonist capsazepine abolishes the antinociceptive action of eugenol and guaiacol. J. Dent. Res. 76 (1997) 848-851
34. Park C.K., Li H.Y., Yeon K.Y., Jung S.J., Choi S.Y., Lee S.J., Lee S., Park K., Kim J.S., and Oh S.B. Eugenol inhibits sodium currents in dental afferent neurons. J. Dent. Res. 85 (2006) 900-904
35. Roy M.L., and Narahashi T. Differential properties of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons. J. Neurosci. 12 (1992) 2104-2111
36. Sell A.B., and Carlini E.A. Anesthetic action of methyleugenol and other eugenol derivatives. Pharmacology 14 (1976) 367-377
37. Thompson D., and Eling T. Mechanism of inhibition of prostaglandin H synthase by eugenol and other phenolic peroxidase substrates. Mol. Pharmacol. 36 (1989) 809-817
38. Trang T., McNaull B., Quirion R., and Jhamandas K. Involvement of spinal lipoxygenase metabolites in hyperalgesia and opioid tolerance. Eur. J. Pharmacol. 491 (2004) 21-30
39. Wie M.B., Won M.H., Lee K.H., Shin J.H., Lee J.C., Suh H.W., Song D.K., and Kim Y.H. Eugenol protects neuronal cells from excitotoxic and oxidative injury in primary cortical cultures. Neurosci. Lett. 225 (1997) 93-96
40. Won M.H., Lee J.C., Kim Y.H., Song D.K., Suh H.W., Oh Y.S., Kim J.H., Shin T.K., Lee Y.J., and Wie M.B. Postischemic hypothermia induced by eugenol protects hippocampal neurons from global ischemia in gerbils. Neurosci. Lett. 254 (1998) 101-104
41. Xu H., Delling M., Jun J.C., and Clapham D.E. Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat. Neurosci. 9 (2006) 628-635
42. Yang B.H., Piao Z.G., Kim Y.B., Lee C.H., Lee J.K., Park K., Kim J.S., and Oh S.B. Activation of vanilloid receptor 1 (VR1) by eugenol. J. Dent. Res. 82 (2003) 781-785
43. Yang Y., Wang Y., Li S., Xu Z., Li H., Ma L., Fan J., Bu D., Liu B., Fan Z., Wu G., Jin J., Ding B., Zhu X., and Shen Y. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J. Med. Genet. 41 (2004) 171-174
44. v1.8 is essential for pain at low temperatures. Nature 447 (2007) 855-858